TSBX: turnstonebio.com Cash Calculated per Single Share

Turnstone Biologics Corp. - graphic logo of issuer TSBX

The development of Turnstone Biologics (TSBX) relies on the efficacy of TIL therapy and the speed of creating personalized cells. On GURU.Markets, the issuer's cash per share demonstrates liquidity, where 0.79 captures the value of this parameter. Simultaneously, the company is implementing energy saving in its laboratories, which facilitates the expansion of its medical center network due to high demand for the treatment of solid tumors.

Turnstone Biologics Corp (TSBX) - Cash per Share from 02/21/2024 to 08/24/2025

Comprehensive metric breakdowns and analytics for Turnstone Biologics Corporation (TSBX)

- current quotes and average value forecast:
- cash availability and cash flow indicators:
Comprehensive company analysis:Turnstone Biologics Corporation (TSBX)
Flagship merchandise of Turnstone Biologics Corp

Liquidity control is a key element of risk management when establishing a long-term position. For Turnstone Biologics (TSBX), which focuses on its own tumor research without external mergers, a capital reserve is critically important. The cash per share trend reflects the volume of free funds attributable to a single security, allowing for the tracking of the resource burn rate. A decline in this metric signals liquidity erosion prior to official reports, while a high value confirms the financial stability of Turnstone Biologics (TSBX) upon the completion of early-stage tests.